A strategy for generating consistent long-term donor-specific tolerance to solid organ allografts

Transplant Immunology

Volumn 5, Issue 2, 1997, Pages 83-88

  Levy, A E ^a   Alexander, J W ^a   Babcock, G F ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 4; RAPAMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MIXED LYMPHOCYTE REACTION; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE;

EID: 0030801042     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(97)80047-0     Document Type: Article

References (25)

1. Terasaki P, Yuge J, Cecka J, Gjertson D, Takemoto S, Cho T. Thirty year trends in clinical kidney transplantation. Clin Transplant 1993: 553-62.
2. Conrad S, Chhabra A, Vay D. Long-term follow-up and complications after cardiac transplantation. J Louisiana State Med Soc 1993; 145: 217-20.
3. Barret W, First M, Aron B, Penn I. Clinical course of malignancies in renal transplant recipients. Cancer 1993; 72: 2186-89.
4. Davies C, Madden R, Alexander JW, Cofer B, Fisher R, Anderson P. Effect of a short course of rapamycin, cyclosporine and donor-specific transfusion on rat cardiac allograft survival. Transplantation 1993; 55: 1107-12.
5. Knight R, Polokoff E, Martinelli G. Rapamycin, cyclosporine, and perioperative donor-specific blood transfusions induce prolongation of cardiac allograft survival in the rat. Transplantation 1994; 53: 1014-20.
6. Cofer B, Davies C, Alexander JW, Tchervenkov, J, Fisher R. Effects of pre- and post-engraftment of donor-specific transfusions and cyclosporine on enhancement of experimental allograft survival. J Surg Research 1992; 52: 663-67.
7. Chen H, Wu J, Xu D, Luo H, Daloze P. Reversal of ongoing heart, kidney, and pancreas allograft rejection and suppression of accelerated heart allograft rejection in the rat by rapamycin. Transplantation 1993; 56: 661-66.
8. Ferraresso M, Wang M, Strepkowski S, Kahan B. Rescue therapy with rapamycin: an ongoing process of heart rejection. Transplant Proc 1993; 25: 729.
9. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 57: 225-29.
10. Babcock GF, Smith LA, Alexander JW. A comparison of single and multiple blood transfusions in the mixed lymphocyte response of rats. Transplant Proc 1988; 20: 1213-16.
11. Babcock GF, Alexander JW. The effects of blood transfusion on cytokine production by TH1 and Th2 lymphocytes in the mouse. Transplantation 1996; 61: 465-68.
12. Madden J, Krug N, Lackie P et al. Detection of IFNγ and IL-2 in T lymphocytes by flow cytometry and confocal microscopy. Cytometry 1994; 7 (suppl.): 64.
13. Babcock GF, Taylor AF, Hynd BA, Sramkoski RM, Alexander JW. Flow cytometric anlaysis of lymphocyte subset phenotypes comparing normal children and adults. Diagn Clin Immunol 1987; 5: 175-79.
14. Babcock GF, Sramkoski R M, Alexander JW. The advantages and disadvantages of the routine use of three color immunofluorescence and flow cytometry in the research and clinical laboratories to study leukocytes. Crit Rev Biotechnol Bioeng 1994; 1: 235-67.
15. Billingham RE, Brent L, Medawar PE. Actively acquired tolerance of foreign cells. Nature 1953; 172: 603-606.
16. Sachs D. CCETS Basic Science Lecture. Transplantation tolerance. Ann Thorac Surg 1993; 56: 1221-27.
17. Wood K. Transplantation tolerance. Curr Opin Immunol 1991; 3: 710-14.
18. Wood K. Alternative approaches for the induction of transplantation tolerance. Immunol Lett 1991; 29: 133-37.
19. Cooper M, Gregory S, Thomson A, Fung J, Starzl T, Wing E. Evaluation of the influence of FK506, rapamycin and cyclosporine on processing and presentation of particulate antigen by macrophages: assessment of a drug 'carry-over' effect. Transplant Proc 1991; 23: 2957-58.
20. Takeuchi T, Lowery R, Konieczny B. Heart allografts in murine systems. The differential activation of Th2-like effector cells in peripheral tolerance. Transplantation 1992; 53: 1281-94.
21. Yuzawa K, Otsuka M, Yu Y et al. Immunosuppressive factors in patients after donor-specific transfusion with the administration of cyclosporine. Transplant Proc 1991; 23: 1036-38.
22. Mottram P, Mmirisklavos A, Dumble L, Clunie G. T suppressor cells induced by transfusions and cyclosporine. Studies in the murine cardiac allograft model. Transplantation 1990; 50: 1033-37.
23. Horuzsko A, Gyodi E, Reti M et al. Non-cytotoxic blocking antibodies and suppressor cells induced by donor-specific transfusions in healthy volunteers and potential kidney transplant recipients. Immunol Lett 1990; 26: 127-30.
24. Morris R, Meisser B, Wu J, Shorthouse R, Wang J. Use of rapamycin for the suppression of alloreactions in vivo: schedule dependence, tolerance induction, synergy with cyclosporine and FK506, and effect of host-versus-graft and graft-versus-host reactions. Transplant Proc 1991; 23: 521-24.
25. Ferraresso M, Ghobrial R, Strepkowski S. The mechanism of unresponsiveness to allografts induced by rapamycin and rapamycin/cyclosporine treatment in rats. Transplantation 1993; 55: 888-94.